1-methyltryptophan has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abu-Zahra, F; Ahmed, MB; Asfour, IA; El Kholy, NM; Habib, HZ; Hammouda, JA; Sallam, MM; Sallam, RM | 1 |
1 other study(ies) available for 1-methyltryptophan and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
Topics: Adult; Antibiotics, Antineoplastic; Blast Crisis; Case-Control Studies; Doxorubicin; Drug Therapy, Combination; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tryptophan; Tumor Cells, Cultured | 2011 |